Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Placebo (USP sterile saline for injection)
BIOLOGICAL
2 trials
Sponsors
DynPort Vaccine Company LLC, A GDIT Company
Conditions
Botulism
Botulism Vaccine
Phase 2
Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
Completed
NCT00764634
DynPort Vaccine Company LLC, A GDIT Company
Botulism Vaccine
Start: 2008-09-30
End: 2010-12-31
Updated: 2011-12-02
Phase 3
Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B
Withdrawn
NCT01940315
DynPort Vaccine Company LLC, A GDIT Company
Botulism
Start: 2017-10-31
End: 2019-09-30
Updated: 2018-12-04